What is the address of MK MED?

The registered office of MK MED is located at Kersbeeklaan 308, 1180 Ukkel.

Is MK MED still active?

Yes. According to the CBE (16 September 2026) MK MED is active, legal situation “Normale toestand”, started on 20 June 2023.

Is MK MED registered on Peppol?

Yes, MK MED is registered on the Peppol network with ID 0208:0802909778.

What is the enterprise number of MK MED?

The enterprise number of MK MED is BE0802909778.

When was MK MED founded?

MK MED was founded on 20 June 2023.

Who are the directors of MK MED?

According to the 2025 annual accounts, the directors of MK MED are: Maria Karimi.

Is MK MED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 June 2023; 3 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MK MED make in 2025?

MK MED posted a profit after taxes of € 12,474 in financial year 2025.

What is the revenue of MK MED?

As a small company, MK MED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 36,523.

MK MED (Private Limited) - Ukkel - BE0802909778

Dossier MK MED, printed on 16 September 2026 from databakkes.be/en/0802909778/mk-med. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Busy address KBO

102 other companies have their registered office at the same address; threshold 10.

Financials

Financial year 2025

MK MED from Ukkel, company number BE0802909778, closed financial year 2025 with a result of € 12,474 after tax. For that financial year MK MED recorded a gross margin of € 36,523 and equity of € 53,821. Compared with financial year 2024, the result moved from € 295 to € 12,474. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.

What it is worth Growing

€ 53,821

▲ 30% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 12,474

▲ € 12,180 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 52,195

▼ 3% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 51,321.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost estimate Staff cost at a one-person company Staff Only people on the payroll count here.€ 140 Likely the director’s social contribution or pension premium.The director’s pay Already netted into the gross margin, not shown separately in the accounts. Typical for one-person companies € 45,000 gross per year minimum for the reduced tax rate≈ € 2,100 net per month after contributions, tax and usually some benefits in kind, roughly Assumption based on the chart of accounts, not a figure from the source.

€ 140

No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.

Vehicles and equipment

€ 337

▼ 68% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 97

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,487

▼ 60% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 55,094 Gross margin 2023: € 55,094 First fiscal year in the series	€ 42,628 Gross margin 2024: € 42,628 ▼ 23% vs 2023 (€ 55,094) Unfavourable step	€ 36,523 Gross margin 2025: € 36,523 ▼ 14% vs 2024 (€ 42,628) Unfavourable step	▼ 14%
Profit after taxes	€ 39,351 Profit after taxes 2023: € 39,351 First fiscal year in the series	€ 295 Profit after taxes 2024: € 295 ▼ 99% vs 2023 (€ 39,351) Unfavourable step	€ 12,474 Profit after taxes 2025: € 12,474 ▲ € 12,180 vs 2024 (€ 295) Favourable step	▲ € 12,180
Equity	€ 41,051 Equity 2023: € 41,051 First fiscal year in the series	€ 41,346 Equity 2024: € 41,346 ▲ 1% vs 2023 (€ 41,051) Favourable step	€ 53,821 Equity 2025: € 53,821 ▲ 30% vs 2024 (€ 41,346) Favourable step	▲ 30%
Total debts	€ 17,370 Total debts 2023: € 17,370 First fiscal year in the series	€ 37,672 Total debts 2024: € 37,672 ▲ 117% vs 2023 (€ 17,370) Unfavourable step	€ 9,144 Total debts 2025: € 9,144 ▼ 76% vs 2024 (€ 37,672) Favourable step	▼ 76%
Cash	€ 26,127 Cash 2023: € 26,127 First fiscal year in the series	€ 53,766 Cash 2024: € 53,766 ▲ 106% vs 2023 (€ 26,127) Favourable step	€ 52,195 Cash 2025: € 52,195 ▼ 3% vs 2024 (€ 53,766) Unfavourable step	▼ 3%
Retained profit	€ 38,551 Retained profit 2023: € 38,551 First fiscal year in the series	€ 38,846 Retained profit 2024: € 38,846 ▲ 1% vs 2023 (€ 38,551) Favourable step	€ 51,321 Retained profit 2025: € 51,321 ▲ 32% vs 2024 (€ 38,846) Favourable step	▲ 32%
Dividend	€ 800 Dividend 2023: € 800 First fiscal year in the series	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 800) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 58,422 Balance sheet total 2023: € 58,422 First fiscal year in the series	€ 79,018 Balance sheet total 2024: € 79,018 ▲ 35% vs 2023 (€ 58,422) Unchanged	€ 62,965 Balance sheet total 2025: € 62,965 ▼ 20% vs 2024 (€ 79,018) Unchanged	▼ 20%

Key figures of MK MED, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MK MED?

What happened at MK MED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 24, 2026 New annual accounts for financial year 2025: profit of € 12,474 (▲ € 12,180 vs 2024). Source: NBB ↗
Jun 20, 2023 New establishment in Oudergem. KBO
2023 Maria Karimi became a director. NBB
Jun 20, 2023 Start of the company according to the CBE. KBO

In short

From € 39,351 profit in 2023 to € 12,474 profit in 2025.

Paid € 21,731 in corporate taxes since 2023.

Best year ever: 2023, with € 39,351 profit.

Paid out € 800 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at MK MED? We notify you, reason included.

Follow MK MED

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Maria Karimi

MK MED

Behind MK MED is Maria Karimi.

See the full network in the app

Directors

According to the 2025 annual accounts

Maria Karimi

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Kersbeeklaan 308

1180 Ukkel

2.350.306.238

Charles Madouxlaan 34

1160 Oudergem

Active since 20 June 2023

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 102 companies are registered at this address.

All companies at this address →

qabirim

CASSART SPECIAL PRODUCTS

€ 2.2 million gross margin · 2025

TERRE & FEU

€ 41,948 gross margin · 2024

CPAPA

€ 3,417 gross margin · 2025

DG Consult-Horsinvest

€ -95,380 gross margin · 2025

+97 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0802.909.778
VAT number: BE 0802.909.778
Registered office: Kersbeeklaan 308, 1180 Ukkel
Names & denominations: MK MED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 June 2023
Peppol: Active · Active since 22 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗